Pharmaceuticals and Healthcare Reports Atypical Hemolytic Uremic Syndrome (Nondiarrhea- A | Página 2

Radiant Insights's Pharmaceutical and Healthcare latest pipeline guide Atypical Hemolytic Uremic
Syndrome - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics
under development for Atypical Hemolytic Uremic Syndrome (Gastrointestinal), complete with
analysis by stage of development, drug target, mechanism of action (MoA), route of administration
(RoA) and molecule type. The guide covers the descriptive pharmacological action of the
therapeutics, its complete research and development history and latest news and press releases.
The Atypical Hemolytic Uremic Syndrome (Gastrointestinal) pipeline guide also reviews of key
players involved in therapeutic development for Atypical Hemolytic Uremic Syndrome (Nondiarrhea-
Associated Hemolytic Uremic Syndrome) and features dormant and discontinued projects. The guide
covers therapeutics under Development by Companies /Universities /Institutes, the molecules
developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1,
2, 3 and 1 respectively.
Atypical Hemolytic Uremic Syndrome (Gastrointestinal) pipeline guide helps in identifying and
tracking emerging players in the market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive advantage. The guide is built
using data and information sourced from Radiant Insights's proprietary databases,
company/university websites, clinical trial registries, conferences, SEC filings, investor presentations
and featured press releases from company/university sites and industry-specific third party sources.
Additionally, various dynamic tracking processes ensure that the most recent developments are
captured on a real time basis.
Request a Sample Copy of This Report @
http://www.radiantinsights.com/research/atypical-hemolytic-uremic-syndrome-
nondiarrhea-associated-hemolytic-uremic-syndrome-pipeline-review-h1-2017/request-
sample
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Atypical Hemolytic
Uremic Syndrome (Gastrointestinal).
- The pipeline guide reviews pipeline therapeutics for Atypical Hemolytic Uremic Syndrome
(Gastrointestinal) by companies and universities/research institutes based on information derived
from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from
pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise,
product description, descriptive licensing and collaboration details, R&D brief, MoA & other
developmental activities.
Follow Us: